IOBT
IO Biotech, Inc.—
Median target
$2.18
range $0.3600–4.00
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- EstimatesRISING
Current-quarter EPS estimate −$0.190 → −$0.140 over 90 days. 1 up, 0 down in 30 days.
The Street
last action Jan 2026Recent actions
| Date | Firm | Rating |
|---|---|---|
| Jan 26, 2026 | Piper Sandler DOWNGRADE | Neutral |
| Oct 22, 2025 | Piper Sandler MAINTAIN | Overweight |
| Sep 30, 2025 | TD Cowen DOWNGRADE | Hold |
| Sep 29, 2025 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Aug 12, 2025 | Morgan Stanley MAINTAIN | Overweight |
| Apr 1, 2025 | HC Wainwright & Co. REITERATE | Buy |
Earnings setup
Estimates−$0.14
EPS estimate, this quarter
+26%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
−$0.19090d
−$0.14060d
−$0.22530d
−$0.2257d
−$0.140Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.14 | -$0.14–-$0.14 | +37.8% | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | -$0.88 | -$0.88–-$0.88 | +11.1% | $0.00 |
| Next FY | -$0.36 | -$0.36–-$0.36 | +2.7% | $0.00 |
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 11, 2026 Earnings calendar
IOBT Q1 2026 Earnings Scheduled — 2026-05-11
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
May 11, 2026
Earnings date
IOBT Q1 2026 Earnings Scheduled — 2026-05-11
May 4, 2026
Earnings date
IOBT Q1 2026 Earnings Scheduled — 2026-05-04
May 1, 2026
Earnings date
IOBT Q1 2026 Earnings Scheduled — 2026-05-01
Apr 15, 2026
Earnings date
IOBT Q4 2025 Earnings After Market Close — 2026-04-15
Apr 13, 2026
Earnings date
IOBT Q4 2025 Earnings After Market Close — 2026-04-13